Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
02/2004
02/12/2004WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
02/12/2004US20040030155 One pot process; halogenation an acid; reacting with base
02/12/2004US20040030149 Chlorinating an isothiocyanate; cyclization
02/12/2004US20040030148 Catalytic process for the preparation of thiazole derivatives
02/12/2004US20040030147 Method for synthesizing epothilones and epothilone analogs
02/12/2004US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
02/12/2004US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects
02/12/2004US20040029946 Topical applying
02/12/2004US20040029940 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus
02/12/2004US20040029939 Inhibitors of IMPDH enzyme
02/12/2004US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/12/2004US20040029926 Thiazolidinone nitrate salt
02/12/2004US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders
02/12/2004US20040029920 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives
02/12/2004US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
02/12/2004US20040029902 2,4-Pyrimidinediamine compounds and their uses
02/12/2004US20040029898 Anticancer agents
02/12/2004US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders
02/12/2004US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders
02/12/2004US20040029886 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
02/12/2004US20040029881 Herbicides, and chemical intermediates thereof
02/12/2004US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
02/12/2004US20040029874 Anticoagulants; cardiovascular disorders
02/12/2004US20040029871 Pharmaceutical compounds for treating copd
02/12/2004US20040029867 Anticoagulants; cardiovascular disorders
02/12/2004US20040029862 Alzheimer's disease
02/12/2004US20040029858 Antitumor agents; solid tumors of rectum, lungs
02/12/2004US20040029857 Anticancer agents; central nervous system disorders; antiinflamamtory agents
02/12/2004DE10234975A1 New effector conjugates of epithilones useful to treat e.g. diseases associated with proliferative processes, neurodegenerative diseases, multiple sclerosis, Alzheimer's disease and rheumatoid arthritis
02/12/2004DE10234425A1 Substituierte Thiazine als Materialschutzmittel Substituted Thiazines as a material preservative
02/12/2004DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments
02/12/2004CA2494616A1 Furanthiazole derivatives as heparanase inhibitors
02/12/2004CA2494593A1 4-trifluormethylpyrazolyl-substituted pyridines and pyrimidines
02/12/2004CA2494139A1 Biaryl compounds having anti-infective activity
02/12/2004CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
02/12/2004CA2492437A1 New effector conjugates, process for their production and their pharmaceutical use
02/11/2004EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
02/11/2004EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
02/11/2004EP1387843A1 Method for obtaining pioglitazone as an antidiabetic agent
02/11/2004EP1387842A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
02/11/2004EP1387833A1 Protease-inhibitors
02/11/2004EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides
02/11/2004EP1299356B1 Novel compounds
02/11/2004EP1032561B1 Substituted oximes as neurokinin antagonists
02/11/2004CN1474810A Substituted urea neuropeptide YY5 antagonists
02/11/2004CN1474803A Novel amide derivatives and medicinal use thereof
02/11/2004CN1474652A Substituted 4,5-dihydro-1,2,4-triazin -6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
02/11/2004CN1473827A 3-position substituted quinolone derivativers and its use in pharmacy
02/11/2004CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
02/11/2004CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
02/11/2004CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
02/10/2004US6689883 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
02/10/2004US6689802 Polymorphs of an epothilone analog
02/10/2004US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/10/2004US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
02/10/2004US6689786 Sulfonylurea, sulfonylthiourea, sulfonylguanidine, sulfonylcyanoguanidine and acylsulfonamide derivatives; antithrombotics
02/10/2004US6689782 3-piperazinyl-2-diarylurea-quinazolinone derivatives; potentiators of antifungal agents
02/10/2004US6689780 Heteroroaromatic amides as inhibitor of factor Xa
02/10/2004US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase
02/10/2004US6689770 Aryl sulfonyls as factor Xa inhibitors
02/10/2004US6689754 Heterocyclic glycyl β-alanine derivatives
02/10/2004CA2108903C Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
02/05/2004WO2004011461A1 Isothiazole derivatives useful as anticancer agents
02/05/2004WO2004011460A2 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
02/05/2004WO2004011457A1 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
02/05/2004WO2004011448A1 Therapeutic compounds for treating dyslipidemic conditions
02/05/2004WO2004011446A1 Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics
02/05/2004WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
02/05/2004WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
02/05/2004WO2004011436A1 Quinoline derivatives and their use as mycobacterial inhibitors
02/05/2004WO2004011425A2 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives
02/05/2004WO2004011410A1 Chemical compounds
02/05/2004WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
02/05/2004WO2004010945A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
02/05/2004WO2004010944A2 Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
02/05/2004WO2004010761A2 Pesticidal cyanine dye derivatives
02/05/2004WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa
02/05/2004US20040024222 Such as 5-(4-(2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy)-benzo(b)thiophen-7 -ylmethyl)2,4-thiazolidinedione via bromo-/chloro-methylation; for treatment of diabetes
02/05/2004US20040024208 Cyclic protein tyrosine kinase inhibitors
02/05/2004US20040024190 Viral polymerase inhibitors
02/05/2004US20040024041 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
02/05/2004US20040024030 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals
02/05/2004US20040024029 Thiazole and oxazole derivatives
02/05/2004US20040024027 5(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
02/05/2004US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases
02/05/2004US20040023981 Salt forms of 4-(2-(5-cyanothiazol-2-ylamino)-pyridin-4-ylmethyl) piperazine-1-carboxylic acid methylamide which inhibit, regulate and/or modulate tyrosine kinase signal transduction,
02/05/2004US20040023980 Polymorphs with tyrosine kinase activity
02/05/2004US20040023979 Process for preparing substituted thiazolyl-amino pyridines, which are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases.
02/05/2004US20040023978 Active salt forms with tyrosine kinase activity
02/05/2004US20040023977 Process for preparing substituted thiazolyl-amino pyrimidinyl piperazines, which are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinase
02/05/2004US20040023974 Pharmacological agents which are inhibitors of PTPases, in particular, the compounds of formula I inhibit PTP-1B and TC PTP, and thus may be employed for the treatment of conditions associated with PTPase activity. The compounds of the present
02/05/2004US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
02/05/2004US20040023963 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
02/05/2004US20040023958 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.
02/05/2004US20040023945 Cyclic amp-specific phosphodiesterase inhibitors
02/05/2004US20040023890 Drugs for diabetes
02/05/2004US20040023807 3-Arylisothiazoles of the formula I and their use for controlling harmful plants, are described.
02/05/2004DE10234875A1 4-Trifluormethylpyrazolyl substituierte Pyridine und Pyrimidine 4-substituted pyridines and pyrimidines Trifluormethylpyrazolyl
02/05/2004DE10234288A1 Metallkomplexe als lichtabsorbierende Verbindungen in der Informationsschicht von optischen Datenträgern Metal complexes as light-absorbing compounds in the information layer of optical media
02/05/2004DE10232094A1 5-Thiaepothilone und 15-disubstituierte Epothilone 5-Thiaepothilone and 15-disubstituted epothilones